ImpediMed Limited (ASX:IPD)
Australia · Delayed Price · Currency is AUD 0.0060
0.00 (0.00%)
Aug 7, 2026, 4:10 PM AEST
ImpediMed Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, ImpediMed stock has a consensus rating of "Strong Buy" and an average price target of $0.02. The average 1-year stock price forecast is 233.33% higher than the current stock price, while the lowest is $0.01 (+66.67%) and the highest is $0.04 (+566.67%).
Price Target: $0.02 (+233.33%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for ImpediMed stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bell Potter | Bell Potter | Buy Maintains $0.01 | Buy | Maintains | $0.01 | +66.67% | Jul 29, 2026 |
| Morgans | Morgans | Buy Maintains $0.02 → $0.01 | Buy | Maintains | $0.02 → $0.01 | +66.67% | Jul 29, 2026 |
| Ord Minnett | Ord Minnett | Buy Maintains $0.05 → $0.02 | Buy | Maintains | $0.05 → $0.02 | +233.33% | May 12, 2026 |
Financial Forecast
Revenue This Year
14.72M
from 12.72M
Increased by 15.69%
Revenue Next Year
19.64M
from 14.72M
Increased by 33.40%
EPS This Year
-0.01
from -0.01
EPS Next Year
-0.00
from -0.01
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.